PharmaShots | Incisive News in 3 Shots

Subscribe Now

Precigen

Precigen Reports EC’s Orphan Drug Designation to PRGN-2012 to Treat Recurrent Respiratory Papillomatosis (RRP)

Precigen Reports EC’s Orphan Drug Designation to PRGN-2012 to Treat Recurrent Respiratory Papillomatosis (RRP)

January 17, 2024

Precigen Receives the US FDA’s IND Clearance of PRGN-2009 + Pembrolizumab for the Treatment of Recurrent or Metastatic Cervical Cancer

Precigen Receives the US FDA’s IND Clearance of PRGN-2009 + Pembrolizumab for the Treatment of Recurrent or Metastatic Cervical Ca...

June 1, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us